Abstract
During the last 50 years, an increasing range of human material has been ‘biobanked’, including blood spots, tissue, and DNA. More recently, the phenomenon of ‘brain banking’ (BBing) – the collection and storage of post-mortem brain tissue to create a research resource for investigation into neurological (especially neurodegenerative) disorders such as Alzheimer’s disease and dementia – has become de rigueur. This is at a time when social and policy concerns abound regarding the problems of an ‘ageing population’. Indeed, the desire to understand and act upon the brain – an object of increasing ‘salience’ and ‘biovalue’ – drives much technoscientific and biomedical innovation, including developments such as brain imaging, scanning, and surgery. Brain research, however, raises a number of concerns which vex not only regulators but also scientists and health-care professionals who are involved in BBing. Key issues include (but are not limited to):
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
